Oxygenta Pharmaceutical (BOM:524636) LT-Debt-to-Total-Asset : 0.78 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Oxygenta Pharmaceutical's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.78.

Oxygenta Pharmaceutical's long-term debt to total assets ratio declined from Mar. 2023 (1.16) to Mar. 2024 (0.78). It may suggest that Oxygenta Pharmaceutical is progressively becoming less dependent on debt to grow their business.

Oxygenta Pharmaceutical LT-Debt-to-Total-Asset Historical Data

The historical data trend for Oxygenta Pharmaceutical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical LT-Debt-to-Total-Asset Chart

Oxygenta Pharmaceutical Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

1.37

1.33

1.64

1.16

0.78

Oxygenta Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															1.16	-	0.74	-	0.78

Oxygenta Pharmaceutical LT-Debt-to-Total-Asset Calculation

Oxygenta Pharmaceutical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	490.017	/	631.921
	=	0.78

Oxygenta Pharmaceutical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	490.017	/	631.921
	=	0.78

Oxygenta Pharmaceutical (BOM:524636) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Oxygenta Pharmaceutical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxygenta Pharmaceutical (BOM:524636) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032

Website

http://oxygentapharma.com

Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines